China NMPA Product Recall - Arm-type electronic blood pressure monitor

Shenzhen Ailicon Medical Co., Ltd. initiated a voluntary Level III recall of its arm-type electronic blood pressure monitors, as publicly announced by the National Medical Products Administration (NMPA) on May 30, 2022. This action, reported via the Guangdong Provincial Drug Administration website, underscores the company's commitment to ensuring product safety and adherence to regulatory standards within China's medical device landscape. While the precise reasons for the recall, such as specific manufacturing defects or performance issues, are not detailed in this public notice, comprehensive information concerning affected product models, specifications, and batch numbers is referenced as available in the official "Recall Event Report Form." Operating under the stringent regulatory framework of the NMPA, Shenzhen Ailicon Medical Co., Ltd. is undertaking the required actions to remove the implicated devices from the market. This process ensures compliance with national health and safety protocols designed to protect consumers and maintain the integrity of medical products. The company is expected to rigorously follow all NMPA guidelines for the effective management and resolution of this recall event.